Imeik Technology Development Co.,Ltd.

XSEC:300896 Stock Report

Market Cap: CN¥60.8b

Imeik Technology DevelopmentLtd Past Earnings Performance

Past criteria checks 5/6

Imeik Technology DevelopmentLtd has been growing earnings at an average annual rate of 34.9%, while the Biotechs industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 34.1% per year. Imeik Technology DevelopmentLtd's return on equity is 26.7%, and it has net margins of 65.9%.

Key information

34.9%

Earnings growth rate

32.1%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate34.1%
Return on equity26.7%
Net Margin65.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Imeik Technology DevelopmentLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300896 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,0752,026376278
30 Jun 243,0672,016383272
31 Mar 243,0471,972390264
31 Dec 232,8691,858409250
30 Sep 232,6201,695422217
30 Jun 232,5131,642398213
31 Mar 232,1381,404332188
01 Jan 231,9391,264291173
30 Sep 221,9141,236276156
30 Jun 221,6991,118258123
31 Mar 221,6191,061258108
01 Jan 221,448958221102
30 Sep 211,26885818990
30 Jun 211,10171816485
31 Mar 2188956713478
31 Dec 2070944011462
30 Sep 2062737611351
31 Dec 1955830612649
31 Dec 1832112310734
31 Dec 17222826828
31 Dec 1614153600
31 Dec 1511218740
31 Dec 147528360

Quality Earnings: 300896 has high quality earnings.

Growing Profit Margin: 300896's current net profit margins (65.9%) are higher than last year (64.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300896's earnings have grown significantly by 34.9% per year over the past 5 years.

Accelerating Growth: 300896's earnings growth over the past year (19.5%) is below its 5-year average (34.9% per year).

Earnings vs Industry: 300896 earnings growth over the past year (19.5%) exceeded the Biotechs industry 1.3%.


Return on Equity

High ROE: 300896's Return on Equity (26.7%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:40
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Imeik Technology Development Co.,Ltd. is covered by 32 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Jian Jun ZouChasing Securities
Xiyue ZhangChasing Securities